GCDFP-15 (ABT330) Antibody (Ready to Use)
Product Specifications
CAS Number
9007-83-4
Product Name Alternative
Prolactin-inducible protein (Gross cystic disease fluid protein 15; GCDFP-15; Prolactin-induced protein; Secretory actin-binding protein; SABP; gp17)
Swiss Prot
P12273
Host
Mouse
Reactivity
Human
Immunogen
Synthesized peptide derived from human Gross cystic disease fluid protein-15 (GCDFP-15) AA range: 50-146
Target
GCDFP-15
Partner Proteins
Gross cystic disease fluid protein-15 (GCDFP-15)
Clonality
Monoclonal
Source
Mouse, Monoclonal/IgG1, kappa
Applications
IHC
Purification
The antibody was affinity-purified from ascites by affinity-chromatography using specific immunogen.
Dilution
Ready to use for IHC
Modification
Unmodified/Total
Storage Conditions
Store at -20°C/1 year
Specificity
The antibody can specifically recognize human GCDFP-15 protein.
Formulation
The prediluted ready-to-use antibody is diluted in phosphate buffer saline containing stabilizing protein and 0.05% Proclin 300
Available Sizes
Explore Other Products
Browse additional items from our catalog
RPL37P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
VEGFR2, CT (KDR, FLK1, KDR, VEGFR2, Vascular endothelial growth factor receptor 2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1) (MaxLight 750)
VEGFR2, CT (KDR, FLK1, KDR, VEGFR2, Vascular endothelial growth factor receptor 2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1) (MaxLight 750)
FXN (Frataxin, Mitochondrial, Friedreich Ataxia Protein, Frataxin Intermediate Form, Frataxin(56-210), Frataxin(81-210), FRDA, X25)
FXN (Frataxin, Mitochondrial, Friedreich Ataxia Protein, Frataxin Intermediate Form, Frataxin(56-210), Frataxin(81-210), FRDA, X25)